What should you know about platinum-refractory ovarian cancer?

Platinum drugs, such as carboplatin or cisplatin, are commonly used in ovarian cancer treatment. Refractory means the cancer did not respond sufficiently to that treatment or progressed while it was being given, or progressed shortly after it ended. This describes how the tumour has behaved during treatment; it does not describe your choices, effort or outlook as a person.

Your team may review scans, symptoms, examination findings and blood tests to understand the current situation. They may also revisit the original pathology and ask whether tumour profiling or inherited genetic testing could identify treatment information. An appointment with a gynaecological oncologist or medical oncologist can help clarify the available options. General information about ovarian cancer is available under Ovarian Cancer.

Ask for a clear review of the scan findings, the treatment response and the purpose of each proposed option. Depending on the tumour, previous medicines, general health and personal priorities, the plan may involve a different systemic treatment, a clinical trial offered by your centre, or treatment aimed at relieving a particular problem. Chemotherapy is one type of systemic treatment; it is not the only factor in choosing a plan.

Keep a record of pain, bowel or bladder changes, appetite, energy, nausea and any new swelling. Take your medicine list and details of previous chemotherapy to appointments. Ask about early help from palliative care: it can support pain, nausea, sleep, breathlessness, emotional strain and family needs alongside cancer treatment.

Contact your oncology team promptly for worsening abdominal swelling or pain, repeated vomiting, inability to keep fluids down, new constipation with increasing discomfort, reduced urine, fever or sudden weakness. Seek emergency care for severe breathing difficulty, fainting, confusion, uncontrolled pain, heavy bleeding or a rapidly worsening condition. Follow the emergency instructions given by your treatment centre, especially if you are receiving medicines that can affect infection risk or blood counts.

You could ask: What shows that the cancer is refractory? What is the aim of the next treatment? Which side effects need a same-day call? Is tumour profiling or BRCA Genetic Testing relevant to me? Could a procedure, symptom treatment or Palliative Care improve my day-to-day comfort? Who should my family contact outside clinic hours?